Study: NCT00648648

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: adavosertib
Description: adavosertib administered as an oral formulation as either monotherapy or in combination with either gemcitabine, cisplatin, or carboplatin.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: adavosertib
Description: adavosertib administered as an oral formulation as either monotherapy or in combination with either gemcitabine, cisplatin, or carboplatin.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: adavosertib
Description: adavosertib administered as an oral formulation as either monotherapy or in combination with either gemcitabine, cisplatin, or carboplatin.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: adavosertib
Description: adavosertib administered as an oral formulation as either monotherapy or in combination with either gemcitabine, cisplatin, or carboplatin.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: adavosertib
Description: adavosertib administered as an oral formulation as either monotherapy or in combination with either gemcitabine, cisplatin, or carboplatin.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: adavosertib
Description: adavosertib administered as an oral formulation as either monotherapy or in combination with either gemcitabine, cisplatin, or carboplatin.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: adavosertib
Description: adavosertib administered as an oral formulation as either monotherapy or in combination with either gemcitabine, cisplatin, or carboplatin.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: adavosertib
Description: adavosertib administered as an oral formulation as either monotherapy or in combination with either gemcitabine, cisplatin, or carboplatin.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: adavosertib
Description: adavosertib administered as an oral formulation as either monotherapy or in combination with either gemcitabine, cisplatin, or carboplatin.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: adavosertib
Description: adavosertib administered as an oral formulation as either monotherapy or in combination with either gemcitabine, cisplatin, or carboplatin.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: adavosertib
Description: adavosertib administered as an oral formulation as either monotherapy or in combination with either gemcitabine, cisplatin, or carboplatin.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: adavosertib
Description: adavosertib administered as an oral formulation as either monotherapy or in combination with either gemcitabine, cisplatin, or carboplatin.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: adavosertib
Description: adavosertib administered as an oral formulation as either monotherapy or in combination with either gemcitabine, cisplatin, or carboplatin.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: adavosertib
Description: adavosertib administered as an oral formulation as either monotherapy or in combination with either gemcitabine, cisplatin, or carboplatin.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: adavosertib
Description: adavosertib administered as an oral formulation as either monotherapy or in combination with either gemcitabine, cisplatin, or carboplatin.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: adavosertib
Description: adavosertib administered as an oral formulation as either monotherapy or in combination with either gemcitabine, cisplatin, or carboplatin.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: adavosertib
Description: adavosertib administered as an oral formulation as either monotherapy or in combination with either gemcitabine, cisplatin, or carboplatin.